Richard William Versace

This inventor holds 27 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Corporation, Novartis Ag, Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 1984-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard William Versace. Retrieved from https://idiyas.com/inventor/richard-william-versace

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 8)

% Patents Active = 81.5

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 488(Granted Patents)

Location History:

Ringwood, NJ (US) (1984 - 1989)
Wanaque, NJ (US) (1993 - 2015)

Company Filing History:

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

patents

Years Active: 1984-2015

Loading Chart...

Areas of Expertise:

Therapeutic Agents

Anti-Cancer Agents

Deacetylase Inhibitors

Pharmaceutical Compositions

Orally Active Compounds

Penem Production

Hydrazone Substituted Penems

Heterocyclic Compounds

Caprolactams

Antibiotic Penems

Substituted Lactams

Tumor Treatment

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8975248 - Combinations of therapeutic agents for treating cancer (2015-03-10),

2. 7378410 - Substituted lactams and their use as anti-cancer agents (2008-05-27),

3. 7067551 - Deacetylase inhibitors (2006-06-27),

4. 6833384 - Deacetylase inhibitors (2004-12-21),

5. 6599898 - Use of certain substituted caprolactam carbonates and ethers in treating tumors (2003-07-29),

6. 6555533 - Use of certain substituted caprolactams in treating tumors (2003-04-29),

7. 6552065 - Deacetylase inhibitors (2003-04-22),

8. 6413954 - Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors (2002-07-02),

9. 6239127 - Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation (2001-05-29),

10. 5750532 - Pharmaceutically active compounds (1998-05-12),

11. 5618849 - Orally active antiviral compounds (1997-04-08),

12. 5559133 - Orally active antiviral compounds (1996-09-24),

13. 5459144 - Pharmaceutically active compounds (1995-10-17),

14. 5449782 - Orally active antiviral compounds (1995-09-12),

15. 5350772 - Certain substituted phenoxy-methyl phenyl-methoxy benzenes having (1994-09-27),

Title: Richard William Versace: Innovator in Cancer Therapeutics

Introduction

Richard William Versace, based in Wanaque, NJ, has made significant contributions to the field of medicine through his innovative work in cancer research. With a total of 27 patents to his name, he is recognized for his groundbreaking inventions that enhance cancer treatment options for patients.

Latest Patents

Among his latest patents is a combination therapy intended for patients suffering from proliferative diseases or conditions linked to persistent angiogenesis. The therapy incorporates a camptothecin derivative along with various chemotherapeutic agents, including microtubule-active agents, alkylating agents, and several kinase inhibitors, among others. This multifaceted approach aims to improve treatment efficacy and patient outcomes. Another notable invention is related to substituted lactams, specifically caprolactam compounds, which demonstrate promise as anti-cancer agents, further expanding the arsenal against cancer.

Career Highlights

Richard has held pivotal roles in esteemed organizations such as Schering Corporation and Novartis AG. His contributions at these companies have significantly advanced the research and development of therapeutic agents, particularly in oncology. His career is marked by a commitment to enhancing the quality of life for cancer patients through innovative treatment solutions.

Collaborations

Throughout his career, Richard has collaborated with notable peers, including Viyyoor Moopil Girijavallabhan and Ashit K. Ganguly. These collaborations have not only fostered a productive exchange of ideas but have also led to the development of influential therapies designed to combat cancer.

Conclusion

Richard William Versace's innovative spirit and dedication to cancer research exemplify the vital role of inventors in advancing medical science. His patents not only reflect his intellectual prowess but also a compassionate commitment to improving patient care. As he continues to work at the forefront of cancer therapy innovation, his contributions will undoubtedly leave a lasting impact on the field.

Profile summary based on public USPTO records.